Top compounds associated with response to ZNF230


Feature Type Standardized
Nominal ANOVA
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.13 2e-05
mRNA Sorafenib CCLE pan-cancer AAC 0.2 2e-05
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-05
mRNA linifanib GDSC1000 pan-cancer AAC 0.15 3e-05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA AT7867 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA ZM-447439 GDSC1000 pan-cancer AAC 0.14 7e-05
mRNA nelarabine CTRPv2 pan-cancer AAC 0.16 7e-05
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA masitinib GDSC1000 pan-cancer AAC 0.13 7e-05
Download CSV